TONGHUA DONGBAO PHARMACEUTICAL CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.08 CNY | +0.50% |
|
-3.36% | -6.93% |
| May. 15 | Tonghua Dongbao Pharmaceutical Launches Phase 1 Trial for Diabetes Injection in China | MT |
| May. 10 | Dongbao Pharmaceutical's Deputy General Manager to Reduce Stake | MT |
Evolution of the average Target Price on Tonghua Dongbao Pharmaceutical Co., Ltd.
Price target over the last 5 years
History of analyst recommendation changes
7ef2ef2c2b6801f49a5.sinr4rFid3k38CCEGNZ-g89w1gCBqR1Dy88pCFTgof4.h3yTs8IADQF2gFbMdr4U-5UbmjTS33MnoolmeDrU46qHENuV9C5ODU6vGA~8306446cb2e0725bf5186e1568dbfb18
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
10.08
CNY
Average target price
14.36
CNY
Spread / Average Target
+42.46%
High Price Target
15
CNY
Spread / Highest target
+48.81%
Low Price Target
14
CNY
Spread / Lowest Target
+38.89%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
C
EPS Revisions
- Stock Market
- Equities
- 600867 Stock
- Consensus Tonghua Dongbao Pharmaceutical Co., Ltd.
